K213804

Substantially Equivalent

cobas SARS-CoV-2 Qualitative for use on the cobas 6800/8800 Systems

Applicant: Roche Molecular Systems, Inc.
Product code: QQX
Advisory panel: Microbiology
Date received: 2021-12-06
Decision date: 2022-10-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Pleasanton, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.